Tzung-Dau Wang Selected Research

4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamine

5/2022	2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
1/2021	Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions.
1/2021	Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia.
1/2020	2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network.
1/2020	Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.
1/2020	Asian management of hypertension: Current status, home blood pressure, and specific concerns in Taiwan.
1/2020	Current status of ambulatory blood pressure monitoring in Asian countries: A report from the HOPE Asia Network.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tzung-Dau Wang Research Topics

Disease

35	Hypertension (High Blood Pressure) 05/2022 - 01/2013
11	Heart Arrest (Cardiac Arrest) 01/2019 - 08/2009
8	Heart Failure 01/2022 - 02/2010
6	Stroke (Strokes) 01/2022 - 01/2015
6	Out-of-Hospital Cardiac Arrest 02/2017 - 02/2004
5	Chronic Renal Insufficiency 01/2022 - 01/2015
5	Inflammation (Inflammations) 07/2017 - 01/2003
5	Asphyxia (Suffocation) 01/2016 - 11/2008
5	Hypothermia 11/2015 - 08/2009
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 10/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2013
4	Dyslipidemias (Dyslipidemia) 01/2021 - 06/2004
4	Body Weight (Weight, Body) 01/2020 - 10/2010
4	Shock 01/2017 - 12/2011
3	Essential Hypertension 02/2022 - 01/2013
3	Atherosclerosis 01/2022 - 07/2017
3	Masked Hypertension 01/2021 - 01/2020
3	Myocardial Infarction 12/2017 - 09/2006
3	Ventricular Fibrillation 01/2017 - 12/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009 - 02/2004
2	Pathologic Constriction (Stenosis) 01/2021 - 11/2010
2	COVID-19 05/2020 - 01/2020
2	Hyperuricemia 01/2020 - 11/2019
2	Diabetes Mellitus 01/2019 - 08/2007
2	Acute Coronary Syndrome 01/2019 - 08/2007
2	Proteinuria 05/2017 - 01/2015
2	Reperfusion Injury 01/2016 - 01/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2010 - 09/2006
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2009 - 10/2005
2	Insulin Resistance 10/2009 - 11/2007
1	Ischemic Stroke 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Arteriosclerosis 01/2021
1	Hemorrhage 01/2021
1	Erectile Dysfunction 01/2021
1	Weight Loss (Weight Reduction) 01/2021

Drug/Important Bio-Agent (IBA)

16	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 05/2014
7	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 05/2022 - 01/2020
7	SaltsIBA 01/2021 - 10/2010
6	CholesterolIBA 01/2022 - 01/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2006
6	C-Reactive ProteinIBA 11/2010 - 10/2003
4	Angiotensin Receptor AntagonistsIBA 05/2022 - 01/2013
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
4	LipidsIBA 01/2013 - 10/2003
3	SodiumIBA 01/2021 - 01/2015
3	CalciumIBA 01/2021 - 11/2010
3	CreatinineIBA 01/2020 - 11/2007
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 10/2003
3	Insulin (Novolin)FDA Link 12/2013 - 10/2006
3	CD40 Ligand (CD40L)IBA 11/2007 - 10/2003
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2022 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2022 - 01/2013
2	Uric Acid (Urate)IBA 01/2022 - 01/2020
2	PotassiumIBA 01/2021 - 01/2017
2	LDL CholesterolIBA 01/2021 - 10/2009
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 11/2010
2	omega-Chloroacetophenone (Mace)IBA 01/2019 - 12/2017
2	Lidocaine (Xylocaine)FDA LinkGeneric 02/2017 - 01/2017
2	Amiodarone (Amiodarona)FDA LinkGeneric 02/2017 - 01/2017
2	Valsartan (Vals)FDA Link 01/2017 - 01/2013
2	Fatty Acid-Binding ProteinsIBA 08/2014 - 08/2009
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2011 - 09/2009
2	Serum AlbuminIBA 10/2009 - 11/2007
2	ResistinIBA 02/2009 - 10/2006
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2007 - 10/2006
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2007 - 10/2006
2	Endothelin-1 (Endothelin 1)IBA 11/2007 - 10/2006
2	Interleukin-6 (Interleukin 6)IBA 11/2007 - 10/2006
2	AdiponectinIBA 10/2006 - 10/2005
2	Rosiglitazone (Avandia)FDA Link 10/2006 - 02/2004
2	Interleukin-1beta (Interleukin 1 beta)IBA 10/2003 - 01/2003
2	Caspase 3 (Caspase-3)IBA 01/2003 - 04/2002
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 05/2022
1	Carvedilol (Coreg)FDA LinkGeneric 03/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	rostafuroxinIBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	TicagrelorIBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	HDL CholesterolIBA 01/2021
1	MagnesiumIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Dietary SodiumIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2020

Therapy/Procedure

13	Therapeutics 05/2022 - 10/2003
7	Denervation 05/2022 - 05/2019
6	Cardiopulmonary Resuscitation (CPR) 01/2017 - 02/2004
6	Resuscitation 01/2017 - 02/2004
5	Induced Hypothermia 11/2017 - 08/2009
4	Induced Heart Arrest (Cardioplegia) 01/2016 - 11/2008
2	Secondary Prevention 01/2022 - 09/2007
2	Percutaneous Coronary Intervention 11/2017 - 08/2007
1	Tai Ji (Tai Chi Chuan) 01/2021
1	Meditation 01/2021
1	Blood Pressure Monitors 01/2021
1	Relaxation Therapy (Relaxation Technique) 01/2021